The Paradigm Evolves

November 13 – 14, 2019 • Harvard Medical School, Boston, MA

The 15th Annual Personalized Medicine Conference at Harvard Medical School will explore the science, business, and policy issues facing personalized medicine as scientists refine their understanding of how groundbreaking molecular diagnostics augmented by artificial intelligence, advanced data analytics, and digital health applications can empower both physicians and patients with information about how an expanded set of biological characteristics — including those found in the proteome and microbiome — may influence their health and their responses to increasingly impactful therapies.

“
With gene therapies, cell-based regenerative medicine, more targeted therapies, and the introduction of better tools for delivering therapies from digital health apps to artificial intelligence to next-generation sequencing, we’re living in an age of momentous progress and rapid cycles of innovation.
”

— Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute

View Speaker List
“
With new biomarkers coming on line, we probably will be able to diagnose much better who will respond best to therapy. That means we have to develop drugs and diagnostics together.
”

— Paul Stoffels, M.D., Vice Chairman, Executive Committee, Chief Scientific Officer, Johnson & Johnson

View Speaker List
“
It is important that the research, medical, and pharmaceutical communities collaborate to maintain momentum in personalized medicine so that we are able to deliver cutting-edge care and clinical trial opportunities to all patients.
”

— Carl June, M.D., Richard W. Vague Professor in Immunotherapy, University of Pennsylvania

View Speaker List